THE ULTIMATE GUIDE TO SBS88

We identified that a large proportion of mutations in chromatin modifier genes in MSS cancers are a result of the pks+ signature (Fig. 4B). Precisely the same Investigation is noted in Supplementary Fig. ten for MSI cancers, exactly where the dominant causative signature of driver and chromatin gene mutations is as an alternative SPS6 (mismatch f